Drug/vaccine combo experiment being tried on advanced prostate cancer

URO TODAY: An experiment that combines a standard advanced prostate cancer drug treatment with a vaccine to assist the immune system has just begun in the US. READ MORE>

Looking to harness the body’s own immune system to target prostate cancer that has spread to the bones (metastatic) and is unresponsive to standard treatment, investigators have just launched a clinical trial combining vaccine and radiation drug therapy.

The goal is to see if disease progression will be further delayed by adding two different experimental injections to the standard treatment.

Read Full Post »

Nomograms accurately predict prostate cancer progression after salvage radiotherapy

JULY 8: URO TODAY: Research shows the Stephenson nomogram is an important tool to predict prostate cancer progression after salvage radio-therapy (SRT) following radical prostatectomy. It adequately predicts cancer progression with reasonable accuracy. However, the overall modest performance of the model used indicates there is still room for improvement in predictive models for disease progression after SRT. READ MORE>

Read Full Post »